There were 308 shareholders represented virtually or by proxy at the Meeting holding 40,152,300 common shares.
MediPharm Labs Corp.(TSX: LABS) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the results of matters voted on at its annual and special meeting of holders of common shares held on Wednesday, August 5, 2020. The voting results for each of the matters presented at the Meeting are outlined below.
There were 308 shareholders represented virtually or by proxy at the Meeting holding 40,152,300 common shares, representing 29.46% of MediPharm Lab's total issued and outstanding common shares as at the record date for the Meeting. As the Meeting was held virtually, all resolutions were passed by a ballot vote.
1. Election of Directors
Each of the nominees for election as directors was elected as directors of MediPharm Labs for the ensuing year or until their successors are elected or appointed. In addition to those seven (7) nominees set out in the management information circular dated June 29, 2020, Chris Taves and Chris Halyk, who were appointed to MediPharm Labs' board on July 13, 2020, and August 4, 2020, respectively, were nominated by management at the Meeting for election as independent directors of MediPharm Labs. Voting results for the election of the individual directors are as set out below:
2. Appointment of Auditor
KPMG LLP, Chartered Professional Accountants, was appointed auditor of MediPharm Labs until the next annual meeting of the holders of the Shareholders at remuneration to be fixed by the directors. Voting results are as set out below:
3. Omnibus Equity Incentive Plan
The resolutions were passed approving a new omnibus equity incentive plan, as more fully described in the Circular. Voting results are as set out below:
4. Private Placement
The resolutions were passed approving matters related to a private placement transaction, as more fully described in the Circular. Voting results are as set out below:
To learn more about MediPharm Labs, visit the company HQ here.
Disclaimer: Past performance is not an indicator of future performance.
Get the Latest Marijuana News &
Content in your Inbox!
All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors